Literature DB >> 10493082

Compliance in psychoses.

O Kampman1, K Lehtinen.   

Abstract

OBJECTIVE: To review the literature on compliance in psychoses and to evaluate the significance of the different compliance components presented.
METHOD: Different definitions of the term compliance were first gathered. A search covering the years 1974-1997 was conducted in Medline and PsycLit databases using the keywords 'schizophrenia' or 'psychosis' and 'compliance'. The studies that took compliance into account as a separate variable were collected for further analysis.
RESULTS: Unpleasant side-effects of medication, attitudes towards medication, delusional symptoms, substance abuse, insight, and supportive family environment were found to have the strongest correlation with compliance. The influence of cognitive impairment is not clearly proven. Integrated, cognitive-behavioural and psychoeducational treatment models include several methods to improve therapeutic alliance and compliance.
CONCLUSION: As the majority of the studies have concentrated on neuroleptic treatment, the medication-related factors are best documented. In clinical practice, treatment compliance is based on patient-related, medication-related and interactional factors, such as treatment model and therapeutic alliance. Difficulties with insight and cognitive functioning are specific patient-related factors in the treatment of psychoses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493082     DOI: 10.1111/j.1600-0447.1999.tb10842.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  27 in total

1.  Costs of new atypical antipsychotic agents for schizophrenia: does unrestricted access reduce hospital utilization?

Authors:  Daria O'Reilly; David Craig; Leslie Phillips; Ron Goeree; Jean-Eric Tarride; Patrick Parfrey
Journal:  Healthc Policy       Date:  2007-08

2.  Predictors of relapse in Chinese schizophrenia patients: a prospective, multi-center study.

Authors:  Yu-Tao Xiang; Chuan-Yue Wang; Yong-Zhen Weng; Qi-Jing Bo; Helen F K Chiu; Sandra S M Chan; Edwin H M Lee; Gabor S Ungvari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-11-03       Impact factor: 4.328

3.  Partial adherence to antipsychotic medication impacts the course of illness in patients with schizophrenia: a review.

Authors:  Prakash S Masand; Miquel Roca; Martin S Turner; John M Kane
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

4.  Directly observed therapy for clozapine with concomitant methadone prescription: a method for improving adherence and outcome.

Authors:  Nicholas Tze Ping Pang; Mohd Fadzli Mohamad Isa; Vikram Suarn Singh; Ruziana Masiran
Journal:  BMJ Case Rep       Date:  2017-07-27

5.  Fostering Recovery from Life-Transforming Mental Health Disorders: A Synthesis and Model.

Authors:  Carla A Green
Journal:  Soc Theory Health       Date:  2004-11-01

6.  Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Authors:  Martijn J Kikkert; Aart H Schene; Maarten W J Koeter; Debbie Robson; Anja Born; Hedda Helm; Michela Nose; Claudia Goss; Graham Thornicroft; Richard J Gray
Journal:  Schizophr Bull       Date:  2006-08-03       Impact factor: 9.306

7.  What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders.

Authors:  Subho Chakrabarti
Journal:  World J Psychiatry       Date:  2014-06-22

Review 8.  Disengagement from mental health services. A literature review.

Authors:  Aileen O'Brien; Rana Fahmy; Swaran P Singh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-26       Impact factor: 4.328

9.  Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia.

Authors:  Hong Liu-Seifert; David H Adams; Haya Ascher-Svanum; Douglas E Faries; Bruce J Kinon
Journal:  Patient Prefer Adherence       Date:  2007-12-20       Impact factor: 2.711

10.  Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia.

Authors:  Haya Ascher-Svanum; Baojin Zhu; Douglas E Faries; Jonathan P Lacro; Christian R Dolder; Xiaomei Peng
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.